Conexeu Sciences closes $5 million insider-led placement
Alpha Vantage · The Manila Times · · AI-summarised by FinFlash
Conexeu Sciences Inc. (Nasdaq: CNXU) closed a $5 million private placement with significant participation from existing shareholders, management and directors. Proceeds will fund manufacturing scale-up, regulatory testing and preclinical work ahead of a planned FDA 510(k) submission in Q1 2027 for lead wound care device Ten Minute Tissue. Some management and director subscriptions sit in escrow pending stockholder approval.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.